Louisiana Administrative Code

A. The commission bills on a quarterly basis with pumpage charges due as follows: For the period October-December, billing date is January 1; for the period January-March, billing date is April 1; for the period April-June, billing date is July 1; and for the period July-Septembe…

A. The pumping charges for ground water users shall be $65 per million gallons and is to be paid quarterly.

A. A user's account shall be considered delinquent 60 calendar days after the quarterly billing dates, which are specified above. When the 60 calendar days have expired and a user has not paid the pumpage charges, the commission shall inform the user by certified mail, return rec…

A. A user, who has been so notified in accordance with the Section entitled "Determination of When an Account Is Delinquent," herein, who is knowingly and willfully in violation of the provisions of Act 678 and its amendments for failure to pay pumpage charges, shall be subject t…

A. The place of suit to recover this penalty shall be selected by the board, as may be appropriate, in the district court of the parish of the residence of any one of the defendants, or in the district court of the parish where the violation took place. [R.S. 38:3083(A)(1)] B. Su…

A. The council shall have the authority to suspend, revoke or deny renewal of Certificates of Registration upon any violation of R.S. 40:1730.21 et seq., after notice and proper hearing.

A. Notice. If the council receives written information indicating that a person holding a Certificate of Registration (registrant) is violating or has violated any provision of R.S. 40:1730.21 et seq., or this Part, the council, after an informal investigation, by the council adm…

A. Complaint. In the event that the matter is not resolved during the informal proceedings, the council shall file a formal complaint which then shall be forwarded to the registrant, via certified mail, to the address on file with the council. B. Hearing. No hearing shall be cond…

A. Hearings. All hearings conducted before the council or a designated committee shall be in accordance with the Administrative Procedure Act. B. Notice. The hearing notice shall include: 1. a statement of the time, place and nature of the hearing; 2. a statement of the legal aut…

A. A final decision or order adverse to a party in an adjudication proceeding shall be in writing. A final decision shall include findings of fact and conclusions of law. Findings of fact, if set forth in statutory language, shall be accompanied by a concise and explicit statemen…

A. A decision or order in a case of adjudication are subject to rehearing, reopening, or reconsideration by the council, within 10 days from the date of its entry. The grounds for such action shall be either that: 1. the decision or order is clearly contrary to the law and the ev…

A. A registrant who is aggrieved by a final decision or order in an adjudication proceeding is entitled to judicial review whether or not he has applied to the agency for rehearing, without limiting, however, utilization of or the scope of judicial review available under other me…

A. Taxpayers filing individual or corporate income or sales and use tax returns may designate all or any portion of a refund, credit, or vendor's compensation as a donation, or may donate an amount greater than the tax or refund due to the Louisiana Military Family Assistance Fun…

A. General. The standard for valuation of drilling rigs and related equipment is fair market value. Assessors are to valuate and assess each drilling rig individually with the appropriate allowance provided for depreciation and obsolence where necessary. The recommended procedure…

A. Land Rigs Table 1103.A Land Rigs Depth "0" to 7,000 Feet Depth (Ft.) Fair Market Value Assessment $ $ 3,000 221,100 33,200 4,000 271,300 40,700 5,000 279,900 42,000 6,000 305,400 45,800 7,000 385,200 57,800 th 8,000 to 10,000 Feet Depth (Ft.) Fair Market Value Assessment $ $ 8…

A. The name by which a drug is designated shall clearly distinguish and differentiate the drug from any name recognized in an official compendium unless the drug complies in identity with the identity prescribed in an official compendium under such recognized name.

A. A statement that a drug differs in strength, quality, or purity from the standard of strength, quality, or purity set forth for such drug in an official compendium shall show all the respects in which the drug so differs, and the extent of each such difference.

A. A drug or device may be deemed misbranded if any representation in the labeling is false or misleading with respect to another drug or device, or a food or cosmetic.

A. A drug may be deemed misbranded if it contains two or more ingredients and the designation of the drug in the labeling is by a name which includes or suggests the name of one or more but not of all the ingredients are stated elsewhere in the labeling.

A. Where the name which appears on the label of any drug or device is not that of the manufacturer, the name shall be qualified by a phrase which reveals the connection such person has with the drug or device, such as "Manufactured for and Packed by ...," "Distributed by ...", "R…

A. Where a person manufactures, packs, sells, or distributes a drug or device at a place other than his principal place of business, the label may state the principal place of business instead of the actual place where each package of such drug or device was manufactured or packe…

A. The requirement that the label shall contain the name and place of business of the manufacturer, packer or distributor shall not be misleading in any particular.

A. The statement of the quantity of the contents of a package of a drug shall reveal the quantity of the drug in the package, exclusive of wrappers and other material packed with the drug.

A. The statement of the quantity of contents shall be expressed in terms of weight, measure, numerical count, or a combination of numerical count and weight or measure, which are generally used by con­sumers and users of the drug to express quantity thereof and which give accurat…

A. The statement of the quantity of a device shall be expressed in terms of numerical count.

A. A statement of the quantity of contents by weight shall be in terms of the avoirdupois pound, ounce and grain, or of the kilogram, gram and milligram. A statement of the quantity of contents by liquid measure shall be in terms of the United States Gallon of 231 cubic inches an…

A. Statements of the quantity of contents of a drug shall contain only those fractions that are generally used in expressing the quantity of such drug. A common fraction shall be reduced to its lowest terms, a decimal fraction shall not be carried out to more than three places, e…

A. Except as provided for in paragraph §1129, a statement of the quantity of a drug in the terms of weight or measure applicable to such drug under the provisions of §1119 shall express the number of the largest unit specified in §1123 which is contained in the package. For examp…

A. In the case of a drug with respect to which there exists an established custom of stating the quantity of the contents as a fraction of a unit, which unit is larger than the quantity contained in the package; or as units smaller than the largest unit contained therein; the sta…

A. The statement of the quantity of the contents of the package of a drug or device shall express the minimum quantity, or the average quantity. If the statement is not so qualified as to show definitely that the quantity expressed is the minimum quantity, the statement shall be …

A. Where the statement expresses the minimum quantity, no variation below the stated minimum shall be permitted except variations below the stated weight or measure of a drug caused by ordinary and customary exposure, after the drug is introduced into commerce, to conditions whic…

A. Where the statement does not express the minimum quantity, variations shall be permitted: 1. when caused by ordinary and customary exposure, after the drug is introduced into commerce, to conditions which normally occur in good distribution practice and which unavoidably resul…

A. The extent of variations from the stated quantity of the contents permissible under §1133 and §1135 shall be determined by the facts in the case of each shipment or other delivery.

A. The label of a drug or device shall be exempt from compliance with the requirements of R.S. 40:617 (A) (3) (b) if: 1. the statement of the quantity of the contents, as expressed in terms applicable to such drug or device under the provisions of §1117, §1119 and §1121, together…

A. A word, statement or other information required by or under authority of the Act to appear on the label shall be deemed to lack that prominence and conspicuousness required by 617(A)(4) of the Act by reason (among other reasons) if: 1. the failure of such word, statement or in…

A. No exemption depending on insufficiency of label space, as prescribed in relations §1141 and §1185 promulgated under R.S. 40:617 (A) (3), (6) and (7) shall apply if such insufficiency is caused by: 1. the use of label space for any word statement, design or device which is not…

A. All words, statements and other information required by or under authority of the Act to appear on the label or labeling shall appear thereon in the English language.

A. If the label or labeling contains any re presentation in a foreign language, all words, statements, and other information required by or under authority of the Act to appear on the label or labeling shall appear thereon in the foreign language.

A. The name of a substance or derivative required to be borne on the label of a drug by regulation §1163 or R.S. 40:617 (A) (5) and regulations promulgated thereunder shall be the common or usual name of such substance or derivative, unless it is designated solely by a name recog…

A. Each of the following chemical derivatives of a substance named in R.S. 40:617(A)(5) is hereby designated as habit forming. (Please refer to the following table) Parent Substance Description Chemical Derivative Chemical Description of Derivative Barbituric Acid Alurate (5-ally…

A. If the drug is in tablet, capsule, ampoule or other unit form, the statement of the quantity or proportion of the substance or derivative contained therein shall express the weight or measure of the substance or derivative in each such unit. If the drug is not in such unit for…

A. The names and quantities or proportions of all such substances and derivatives, and the statement: "Warning⎯May Be Habit Forming", shall immediately precede or immediately follow (without intervening written, printed or graphic matter) the name by which such drug is titled in …

A. Drugs designated by the Louisiana department as habit forming or dangerous, shall only be sold or dispensed on the original prescription of a physician, dentist or veterinarian. The refilling of such a prescription for any habit forming or dangerous drug, except upon authoriza…

A. A drug shall not be considered to be misbranded by reason of failure of its label to bear the statement "Warning—May Be Habit Forming—" 1. If such drug is not suitable for internal use, and is distributed and sold exclusively for such external use as involves no possibility of…

A. A drug shall be deemed to be misbranded if it is not designated solely by a name recognized in an official compendium, unless its label bears: 1. the common or usual name of the drug, if such there be; and 2. in case it is made from two or more ingredients, the common or usual…

A. The following drugs in therapeutically effective proportions are considered dangerous for use otherwise than on the prescription of a duly qualified physician, dentist, or veterinarian licensed by law to administer drugs: 1. Acetanilid (where dosage provides a total daily inta…

A. The term "dispense" as used in 4.0701 shall mean the use of a drug as an ingredient in the corn pounding of any prescription issued by a physician, dentist, or veterinarian in his professional practice.

A. The terms "physician", "dentist", and "veterinarian", as used in relation to the exemption from any labeling requirement of any drug or device shall include only those physicians, dentists or veterinarians who are licensed by law to administer or apply such drug or device.

A. The name of an ingredient, substance, derivative, or preparation required by §1163 to be borne on the label of a drug shall be the name thereof which is listed in §1163, or if not so listed, shall be a specific name and not a collective name. Where an ingredient is an article …

A. Where a component of a drug contains a substance the quantity or proportion of which is required by §1163.A.2 to appear on the label and the component is not a derivative or preparation of that substance, as defined in §1171, the label shall bear in conjunction with the name o…